Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Luzina, N. Todd, V. Lockatell, S. Atamas (Baltimore, United States Of America). Alternatively spliced Interleukin-4, IL-4δ2, mediates DPLD similar to scleroderma lung disease in an animal model. Eur Respir J 2010; 36: Suppl. 54, 4215

Member's Comments

No comment yet.

Related content which might interest you: Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 The role of chronic inflammation in mouse lung tumourigenesis Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 Strain dependence of lung tissue mechanics in a murine model of chronic asthma Source: Annual Congress 2006 - Respiratory mechanics Year: 2006 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis Source: Eur Respir J 2016; 47:1797-1808 Year: 2016 A short splice variant of the tumor suppressor gene CYLD induces allergic airway disease in mice and is also expressed in humans Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Osteoporosis and inflammation Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Systemic inflammation, genetic susceptibility and lung function Source: Eur Respir J 2008; 32: 92-97 Year: 2008 TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs) Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005